Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Ascend Wellness Holdings, Inc.
- Market Cap
- Unavailable
- Price
- $0.47
- % Change (Daily % change from the live per-ticker quote feed.)
- -1.41%
- Volume
- 27.7K
About
Ascend Wellness Holdings, Inc. operates within the cannabis industry, specializing in the cultivation, processing, and distribution of packaged marijuana products. Its extensive product portfolio encompasses a variety of cannabis forms, including dried flower, pre-rolled joints, concentrated extracts, vaporizable products, edibles, and other related consumer items. As of December 31, 2021, the company maintained a substantial retail presence, with 20 dispensaries in operation. Beyond its own network, Ascend Wellness Holdings additionally supplies its merchandise to other authorized cannabis retailers. Established in 2018, the firm's corporate headquarters are located in New York, New York.
Quick stats
Shares outstanding—
Computed float140.1M
Float / sharesUnknown
Key info
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001756390
Websitehttps://www.awholdings.com
AI Summary
AI-generated1/14
majorbullishearnings
AWH Reports Second Quarter 2026 Financial Results
AWH reported Q2 2026 net revenue of $126.1 million, up 7.9% sequentially, with Adjusted EBITDA of $29.1 million representing a 23.1% margin.
The company generated $19.5 million in free cash flow and grew its retail footprint to 55 locations, while submitting applications for DEA registration under the expedited Schedule III pathway.
A definitive proxy statement was filed for a reverse stock split to support a planned uplisting to a major U.S. exchange, with a shareholder vote scheduled for August 28, 2026.
Red flags
- Wholesale revenue decreased approximately 1% sequentially
- Work stoppage at Barry, Illinois facility in June 2026; company evaluating potential impact on Q3 results